Two innovative projects from the 2015 spring call have been awarded the InnoTREK grant, a financial support that will allow the laureats to mature their ideas towards a start-up project.
Hosted by Professor Buclin, Division of Clinical Pharmacology at the CHUV, Séverine Petitprez will further develop the software EzeCHiel that will assist physicians in monitoring and adjusting the dosage of medicines to individual patients. Combining sophisticated pharmacokinetic algorithms with a personalized, automated and user-friendly approach the tool is poised to rapidly penetrate the market.
“Most central nervous system disorders are poorly detected before first symptoms appear because of a lack of medical tests to diagnose them appropriately. The need for such tests is therefore great. Early diagnosis could significantly enhance chances for successful treatment, and help in the development of personalized medicine” says Robert Lütjens, founder of the BioLemantis project. During his grant period in the laboratory of Professor Ron Stoop, Centre for Psychiatric Neurosciences, he sets out to establish proof of concept for a new biosensor technology to diagnose autism spectrum disorders.
The InnoTREK grant, organised by the PACTT with the support from the FIT as part of the InnoPACTT fund, sponsors selected researchers at UNIL and CHUV who have the ambition to venture into the business world with their innovative projects. The successful projects are chosen in a competitive process from applications received during the two calls per year. Since the launch in 2014, 9 laureates of UNIL-CHUV have benefited from the InnoTREK grant.